Direct effects of adipokines on the heart: focus on adiponectin

Area of Science:

• Endocrinology
• Cardiology
• Metabolic disease

Background:

• Obesity and diabetes are leading causes of death, often involving cardiovascular disease, particularly heart failure.
• The precise mechanisms linking obesity and diabetes to heart disease are complex and require further elucidation.
• Adipokines, hormones secreted by adipose tissue, are increasingly recognized for their endocrine effects on the heart.

Purpose of the Study:

• To review the role of adipokines in the pathogenesis of heart failure.
• To explore how adipokines regulate cardiac remodeling processes such as metabolism, hypertrophy, fibrosis, and cell death.
• To examine the therapeutic potential and biomarker utility of adipokines in heart failure.

Main Methods:

• Comprehensive review of existing scientific literature on adipokines and heart failure.
• Analysis of cellular and mechanistic studies on adipokine actions in the myocardium.
• Integration of findings from in vivo models and clinical studies.

Main Results:

• Adiponectin, while often cardioprotective, can have complex effects in heart failure.
• Lipocalin-2 exhibits pro-inflammatory and pro-apoptotic properties relevant to cardiac dysfunction.
• Adipokines significantly influence key cardiac remodeling events contributing to heart failure.

Conclusions:

• Adipokines are critical mediators in the development of heart failure associated with obesity and diabetes.
• Further research integrating mechanistic and clinical data is needed to fully understand adipokine roles.
• Adipokines hold promise as both diagnostic biomarkers and therapeutic targets for heart failure management.